RHOA and Hepatic fibrosis: Previous studies have shown that miR-125b can promote hepatic stellate cell activation and liver fibrosis by activating RhoA signaling, and antagonizing miR-125b can significantly alleviate liver fibrosis in CCl4-treated mice [17].